KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Staar Surgical (STAA) Invested Capital (2016 - 2025)

Historic Invested Capital for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $353.8 million.

  • Staar Surgical's Invested Capital fell 1736.47% to $353.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $353.8 million, marking a year-over-year decrease of 1736.47%. This contributed to the annual value of $397.3 million for FY2024, which is 294.88% up from last year.
  • Per Staar Surgical's latest filing, its Invested Capital stood at $353.8 million for Q3 2025, which was down 1736.47% from $336.6 million recorded in Q2 2025.
  • Over the past 5 years, Staar Surgical's Invested Capital peaked at $428.1 million during Q3 2024, and registered a low of $198.6 million during Q1 2021.
  • Its 5-year average for Invested Capital is $325.8 million, with a median of $337.7 million in 2023.
  • In the last 5 years, Staar Surgical's Invested Capital surged by 3403.6% in 2021 and then tumbled by 1772.9% in 2025.
  • Over the past 5 years, Staar Surgical's Invested Capital (Quarter) stood at $258.6 million in 2021, then rose by 29.99% to $336.1 million in 2022, then grew by 14.83% to $386.0 million in 2023, then grew by 2.95% to $397.3 million in 2024, then dropped by 10.96% to $353.8 million in 2025.
  • Its last three reported values are $353.8 million in Q3 2025, $336.6 million for Q2 2025, and $350.0 million during Q1 2025.